CN105396043A - Phlegm-coagulation and blood-stagnation type adenomyosis treating traditional Chinese medicine composition - Google Patents
Phlegm-coagulation and blood-stagnation type adenomyosis treating traditional Chinese medicine composition Download PDFInfo
- Publication number
- CN105396043A CN105396043A CN201410460095.5A CN201410460095A CN105396043A CN 105396043 A CN105396043 A CN 105396043A CN 201410460095 A CN201410460095 A CN 201410460095A CN 105396043 A CN105396043 A CN 105396043A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- rhizoma
- radix
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a phlegm-coagulation and blood-stagnation type adenomyosis treating traditional Chinese medicine composition, which is prepared from the following traditional Chinese medicine raw materials by weight: 5-15 parts of pinellia ternata, 5-15 parts of pericarpium citri reticulatae, 10-17 parts of tuckahoe, 10-17 parts of cyperus rotundus, 5-15 parts of ligusticum chuanxiong hort, 10-17 parts of curcuma zedoaria, 10-17 parts of atractylodes lancea, 10-17 parts of common vladimiria root, 5-15 parts of licorice root, 20-28 parts of salvia miltiorrhiza, and 15-25 parts of angelica. According to the present invention, the raw materials have effects of dampness removing, phlegm dissipating, blood circulation activating and blood stasis dissipating, the total effective rate is 93.55%, the clinical symptoms can be improved, and the treatment course can be shortened.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition and application thereof for the treatment of adenomyosis, particularly relate to a kind of Chinese medicine composition for the treatment of expectorant blood stasis type adenomyosis.
Background technology
Adenomyosis is a kind of benign lesion that endometrium intrusion myometrium causes, and is common gynaecopathia.In some factor as under damage, inflammation or the estrogenic stimulation of continual high levels, destroy myometrial defence capability, and impel primary disease to occur.Minority is positioned at the solitary sick point of dark muscle layer, may be caused by endometrium fragment intravascular or lymphatic vessel spread.
Adenomyosis is in motherland's medical science, its clinical symptoms and sign belong to " dysmenorrhea ", " mass in the abdomen ", " menorrhagia ", " menostaxis of the traditional Chinese medical science " etc. sick category; classical symptom is secondary dysmenorrhea, Progressive symmetric erythrokeratodermia increases the weight of, menorrhagia, and menostaxis and uterus increase.
Summary of the invention
For above-mentioned prior art, the invention provides a kind of Chinese medicine composition for the treatment of expectorant blood stasis type adenomyosis, this Chinese medicine composition has damp eliminating and reduces phlegm, effect of blood circulation promoting and blood stasis dispelling, and easy to operation.
The present invention is achieved by the following technical solutions:
Treat a Chinese medicine composition for expectorant blood stasis type adenomyosis, be made up of the raw material of Chinese medicine of following weight:
The Rhizoma Pinelliae 5 ~ 15 parts, Pericarpium Citri Reticulatae 5 ~ 15 parts, 10 ~ 17 parts, Poria, Rhizoma Cyperi 10 ~ 17 parts, Rhizoma Chuanxiong 5 ~ 15 parts, Rhizoma Curcumae 10 ~ 17 parts, Rhizoma Atractylodis 10 ~ 17 parts, the Radix Aucklandiae 10 ~ 17 parts, 5 ~ 15 parts, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 20 ~ 28 parts, Radix Angelicae Sinensis 15 ~ 25 parts.
Preferably, be made up of the raw material of Chinese medicine of following weight:
The Rhizoma Pinelliae 7 parts, Pericarpium Citri Reticulatae 7 parts, 12 parts, Poria, Rhizoma Cyperi 12 parts, Rhizoma Chuanxiong 7 parts, Rhizoma Curcumae 12 parts, Rhizoma Atractylodis 12 parts, the Radix Aucklandiae 12 parts, 7 parts, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 22 parts, Radix Angelicae Sinensis 17 parts.
More preferably, be made up of the raw material of Chinese medicine of following weight:
The Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, 15 parts, Poria, Rhizoma Cyperi 15 parts, Rhizoma Chuanxiong 10 parts, Rhizoma Curcumae 15 parts, Rhizoma Atractylodis 15 parts, the Radix Aucklandiae 15 parts, 10 parts, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 25 parts, Radix Angelicae Sinensis 20 parts.
Above-mentioned medical material is put into marmite, adds the water soaking 2 hours of 4 times of dose weight multiples, decoct 1 hour, filter to obtain medicinal liquid and medicinal residues, in medicinal residues, add the water of 2 times of doses again, decoct 0.5 hour, filter to obtain medicinal liquid, merge the medicinal liquid of twice, to obtain final product.
Adenomyosis is secondary to puerperal, artificial abortion more, examine erasion after, how due to puerperal or postoperative, blood room is just opened, and healthy energy is deficient, and cold-evil takes advantage of a weak point in opponent's defence visitor in born of the same parents, the expectorant blood coagulation stasis of blood; Or internal damage by the excessive seven emotions, stagnation of QI due to depression of the liver, the hematogenous blockage hyperamization stasis of blood; Or stagnation of liver-QI with deficiency of the spleen, transformation failure of spleen, retention of water-damp in the body, insufficiency of kidney-YANG, gasify unable, bringing about the spread of body fluid does not change, and gathers and wets into expectorant, the stagnation of phlegm stagnation of QI, fight mutually tie with blood.The stagnation of QI, cold coagulation, phlegm-damp all can the hyperamization stasis of bloods, and with the passing of time Er Cheng mass in the abdomen is appointed in born of the same parents in the stagnant punching of the stasis of blood; Blood-stasis internal-depression, Chong and Ren channel disorder, then menorrhagia, menostaxis; Functional activity of QI being not smooth, stagnation of QI and blood may bring about pain, so dysmenorrhea.The essence of primary disease is blood stasis is in a word trouble, true card, but for a long time sick, and impairment of body fluid of losing blood consumption gas, causes deficient qi and blood, and change into syndrome of intermingled deficiency and excess.Expectorant blood stasis type adenomyosis is due to stagnation of QI due to depression of the liver or insufficiency of the spleen insufficiency of kidney-YANG, and water-damp not being transformed, gather and wet into expectorant, phlegm-damp is tied in born of the same parents, ties mutually with vim and vigour, with the passing of time Cheng mass in the abdomen.Inside have the heresy of phlegm-damp, can not change precise and tiny is menses, and wet note punching is appointed, so menstruation matter is rare as water; Inside have blood stasis, then menses have block; The stagnation of phlegm stagnation of QI, then chest distress, vomiting and nausea tending to vomit; Damp flowing downward to lower-JIAO, injures and appoints band two arteries and veins, so profuse leukorrhea, color white matter is adjusted; Tongue arteries and veins is resembling of the expectorant blood coagulation stasis of blood.Raw many tools of the present invention damp eliminating is reduced phlegm, blood circulation invigorating efficacies, and total effective rate is 93.55%, can improve clinical symptoms, shortens and treats the course for the treatment of.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated.
Embodiment 1:
Treat a Chinese medicine composition for expectorant blood stasis type adenomyosis, be made up of the raw material of Chinese medicine of following weight proportion:
The Rhizoma Pinelliae 5 grams, Pericarpium Citri Reticulatae 5 grams, 10 grams, Poria, Rhizoma Cyperi 10 grams, Rhizoma Chuanxiong 5 grams, Rhizoma Curcumae 10 grams, Rhizoma Atractylodis 10 grams, the Radix Aucklandiae 10 grams, 5 grams, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 20 grams, Radix Angelicae Sinensis 15 grams.
Embodiment 2:
Treat a Chinese medicine composition for expectorant blood stasis type adenomyosis, be made up of the raw material of Chinese medicine of following weight proportion:
The Rhizoma Pinelliae 15 grams, Pericarpium Citri Reticulatae 15 grams, 17 grams, Poria, Rhizoma Cyperi 17 grams, Rhizoma Chuanxiong 15 grams, Rhizoma Curcumae 17 grams, Rhizoma Atractylodis 17 grams, the Radix Aucklandiae 17 grams, 15 grams, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 28 grams, Radix Angelicae Sinensis 25 grams.
Embodiment 3:
Treat a Chinese medicine composition for expectorant blood stasis type adenomyosis, be made up of the raw material of Chinese medicine of following weight proportion:
The Rhizoma Pinelliae 7 grams, Pericarpium Citri Reticulatae 7 grams, 12 grams, Poria, Rhizoma Cyperi 12 grams, Rhizoma Chuanxiong 7 grams, Rhizoma Curcumae 12 grams, Rhizoma Atractylodis 12 grams, the Radix Aucklandiae 12 grams, 7 grams, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 22 grams, Radix Angelicae Sinensis 17 grams.
Embodiment 4:
Treat a Chinese medicine composition for expectorant blood stasis type adenomyosis, be made up of the raw material of Chinese medicine of following weight proportion:
The Rhizoma Pinelliae 10 grams, Pericarpium Citri Reticulatae 10 grams, 15 grams, Poria, Rhizoma Cyperi 15 grams, Rhizoma Chuanxiong 10 grams, Rhizoma Curcumae 15 grams, Rhizoma Atractylodis 15 grams, the Radix Aucklandiae 15 grams, 10 grams, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 25 grams, Radix Angelicae Sinensis 20 grams.
Clinical data
The embodiment of the present invention 4 be applied to clinical observation case 61 example, at 31 ~ 49 years old age, all patients meet expectorant blood stasis type adenomyosis symptom: menstrual period lower abdomen pain with tenderness, menorrhagia, matter is rare as water, has clot, and uterus increases, chest distress, vomiting and nausea tending to vomit, profuse leukorrhea, color is white, and matter is thick, dark tongue quality tongue is greasy in vain, deep-rolling pulse and string.
Usage and dosage: during clinical practice, the component in compositions, consumption take the circumstances into consideration increase and decrease according to the body weight of patient, age and symptom.One day potion, decocting twice extracting juice 200 ~ 300ml, point early, warmly to take evening twice, period in a medicine avoided eating anything raw or cold, pungent, stimulate and rotten thing, fry, fire are burned and stodgy food should not be eaten more.
Efficacy evaluation:
(1) cure: menstrual period, lower abdomen was without pain, normal through measuring, without nausea and vomiting phenomenon, tongue fur color is normal, and pulse condition is normal;
(2) take a turn for the better: menstrual period, lower abdomen occasionally had pain, slightly many through amount, tongue fur is slightly dark;
(3) do not heal: symptom has no improvement.
Therapeutic effect: in this clinical observation case, takes medicine 2 ~ 30 days, cures 52 examples, and take a turn for the better 6 examples, and invalid 3 examples, cure rate is 85.25%, and total effective rate is 93.55%, and toxic and side effects does not occur treatments period.
Claims (4)
1. treat a Chinese medicine composition for expectorant blood stasis type adenomyosis, it is characterized in that, be made up of the raw material of Chinese medicine of following weight::
The Rhizoma Pinelliae 5 ~ 15 parts, Pericarpium Citri Reticulatae 5 ~ 15 parts, 10 ~ 17 parts, Poria, Rhizoma Cyperi 10 ~ 17 parts, Rhizoma Chuanxiong 5 ~ 15 parts, Rhizoma Curcumae 10 ~ 17 parts, Rhizoma Atractylodis 10 ~ 17 parts, the Radix Aucklandiae 10 ~ 17 parts, 5 ~ 15 parts, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 20 ~ 28 parts, Radix Angelicae Sinensis 15 ~ 25 parts.
2. a kind of Chinese medicine composition for the treatment of expectorant blood stasis type adenomyosis as claimed in claim 1, is characterized in that, be made up of the raw material of Chinese medicine of following weight:
The Rhizoma Pinelliae 7 parts, Pericarpium Citri Reticulatae 7 parts, 12 parts, Poria, Rhizoma Cyperi 12 parts, Rhizoma Chuanxiong 7 parts, Rhizoma Curcumae 12 parts, Rhizoma Atractylodis 12 parts, the Radix Aucklandiae 12 parts, 7 parts, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 22 parts, Radix Angelicae Sinensis 17 parts.
3. a kind of Chinese medicine composition for the treatment of expectorant blood stasis type adenomyosis as claimed in claim 1, is characterized in that, be made up of the raw material of Chinese medicine of following weight:
The Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, 15 parts, Poria, Rhizoma Cyperi 15 parts, Rhizoma Chuanxiong 10 parts, Rhizoma Curcumae 15 parts, Rhizoma Atractylodis 15 parts, the Radix Aucklandiae 15 parts, 10 parts, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae 25 parts, Radix Angelicae Sinensis 20 parts.
4. the Chinese medicine composition described in any one of claim 1-3, it is characterized in that, preparation method is: above-mentioned medical material is put into marmite, adds the water soaking 2 hours of 4 times of dose weight multiples, decocts 1 hour, filter to obtain medicinal liquid and medicinal residues, in medicinal residues, add the water of 2 times of doses again, decoct 0.5 hour, filter to obtain medicinal liquid, merge the medicinal liquid of twice, to obtain final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410460095.5A CN105396043A (en) | 2014-09-11 | 2014-09-11 | Phlegm-coagulation and blood-stagnation type adenomyosis treating traditional Chinese medicine composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410460095.5A CN105396043A (en) | 2014-09-11 | 2014-09-11 | Phlegm-coagulation and blood-stagnation type adenomyosis treating traditional Chinese medicine composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105396043A true CN105396043A (en) | 2016-03-16 |
Family
ID=55462019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410460095.5A Pending CN105396043A (en) | 2014-09-11 | 2014-09-11 | Phlegm-coagulation and blood-stagnation type adenomyosis treating traditional Chinese medicine composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105396043A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104857432A (en) * | 2015-05-15 | 2015-08-26 | 济南科纳信息科技有限公司 | Traditional Chinese medicine composition for treating adenomyosis |
-
2014
- 2014-09-11 CN CN201410460095.5A patent/CN105396043A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104857432A (en) * | 2015-05-15 | 2015-08-26 | 济南科纳信息科技有限公司 | Traditional Chinese medicine composition for treating adenomyosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
CN104306514A (en) | Traditional Chinese medicine spray and preparation method thereof | |
CN103550683B (en) | A kind of Chinese medicine composition of Acne treatment | |
CN103330805B (en) | Traditional Chinese medicine composition for treating menorrhagia | |
CN107496265A (en) | A kind of anti-dandruff and itching-relieving anticreep Chinese medicine shampoo powder and preparation method thereof | |
CN103055116B (en) | Traditional Chinese medicine composition for treating acnes | |
CN103720996A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
CN103272143B (en) | Traditional Chinese medicine composition for treating acne | |
CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
CN104740268A (en) | Traditional Chinese medicinal composition for treating coronary heart disease | |
CN104997882A (en) | Traditional Chinese medicine for treating adenomyosis | |
CN105456909A (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis adenomyosis | |
CN104147509A (en) | Traditional Chinese medicine composition for treating dysmenorrhea | |
CN105396043A (en) | Phlegm-coagulation and blood-stagnation type adenomyosis treating traditional Chinese medicine composition | |
CN105456974A (en) | Traditional Chinese medicine composition for treating congealing cold blood stasis adenomyosis | |
CN102988804A (en) | Chinese medicine composition for treating wind-heat type common cold | |
CN103550642B (en) | A kind of Chinese medicine composition for the treatment of wind-warm lung-heat disease caused by wind-heat invading the lung | |
CN103933269A (en) | Traditional Chinese medicine for treating metrorrhagia disease | |
CN104857432A (en) | Traditional Chinese medicine composition for treating adenomyosis | |
CN104083580A (en) | Traditional Chinese medicine for treating senile dementia | |
CN109663002A (en) | It is a kind of to dry except cold powder for dipping feet and preparation method thereof | |
CN103705783A (en) | Traditional Chinese medicine composition for treating frequent urination, urgent urination and painful urination caused by hyperplasia of prostate | |
CN105617162A (en) | Traditional Chinese medicine composition for treating aphthae | |
CN104606605A (en) | Traditional Chinese medicine composition for treating breast hyperplasia and preparation method for traditional Chinese medicine composition | |
CN104435853A (en) | Traditional Chinese medicine composition for treating coronary heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160316 |
|
WD01 | Invention patent application deemed withdrawn after publication |